Kun-Jian Peng

ZLM-7 inhibits the occurrence and angiogenesis of breast cancer through miR-212-3p/Sp1/VEGFA signal axis

Xuan Li, Zizheng Zou, Min Wen, 2020, Molecular medicine.

Synthesis and anti-OXPHOS, antitumor activities of DLC modified spinosyn derivatives.

Zhi-yong Luo, Kun-Jian Peng, Suyou Liu, 2020, Bioorganic & medicinal chemistry letters.

Synthesis and antiproliferative properties of novel naringenin derivatives

Zhi-yong Luo, Kun-Jian Peng, Suyou Liu, 2017, Medicinal Chemistry Research.

ortho-Substituted C-aryl glucosides as highly potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2010, Bioorganic & medicinal chemistry.

Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2009, Bioorganic & medicinal chemistry letters.

Design, synthesis, and biological evaluation of deuterated C-aryl glycoside as a potent and long-acting renal sodium-dependent glucose cotransporter 2 inhibitor for the treatment of type 2 diabetes.

J. Y. Roberge, Wei-Chang Fu, Kun-Jian Peng, 2014, Journal of medicinal chemistry.

What blocks more anticancer platinum complexes from experiment to clinic: Major problems and potential strategies from drug design perspectives

Z. Mao, Kun-Jian Peng, Wenting Liu, 2021, Coordination Chemistry Reviews.

C-aryl glucosides substituted at the 4'-position as potent and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors for the treatment of type 2 diabetes.

J. Y. Roberge, B. Seed, Huawei Cheng, 2011, Bioorganic & medicinal chemistry letters.

[Expression of LXR-β in human gastric cancer tissue and the effect of GW3965 on the proliferation of gastric cancer cell line SGC-7901].

Kun-Jian Peng, Ruixin Li, Zhikang Chen, 2016, Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences.

Exploration of O-spiroketal C-arylglucosides as novel and selective renal sodium-dependent glucose co-transporter 2 (SGLT2) inhibitors.

B. Seed, Kun-Jian Peng, A. Welihinda, 2009, Bioorganic & medicinal chemistry letters.